Modern possibilities of using immunotherapy in the treatment of cervical cancer

Cervical cancer (CC) is the fourth most common cancer in women worldwide. Every year, more than 500,000 women are diagnosed with CC, and the disease leads to more than 300,000 deaths worldwide. Infection with the human papillomavirus is the cause of CC in most cases. The disease is largely preventab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: A. V. Tarasova, K. A. Ganina, M. A. Meshkova, Yu. V. Solovyeva, E. E. Ivanova, L. N. Akimov
Format: Artigo
Sprache:Russo
Veröffentlicht: ABV-press 2021-09-01
Schriftenreihe:Opuholi Ženskoj Reproduktivnoj Sistemy
Schlagworte:
immunotherapy
pembrolizumab
nivolumab
pd-1
pd-l1
biomarkers
Online Zugang:https://ojrs.abvpress.ru/ojrs/article/view/851
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge